Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine J Lee

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Current Hematologic Malignancy Reports|January 11, 2022
Use of Telemedicine in Care of Hematologic Malignancy Patients: Challenges and OpportunitiesJennifer Lloyd, Catherine J Lee
British Journal of Clinical Pharmacology|January 19, 2011
Direct thrombin inhibitorsCatherine J Lee, Jack E Ansell
JACC. Cardiooncology|January 11, 2024
Ablating Late Cardiovascular Events in Modern Hematopoietic Cell Transplantation: Not There YetRichard K Cheng, Catherine J Lee
Current Hematologic Malignancy Reports|May 24, 2017
Coordination of Care in Survivorship After Treatment of Hematological Malignancies-The Journey is Not Over YetCatherine J Lee, Lori S Muffly
Cancers|August 26, 2023
Telemedicine in Hematopoietic Cell Transplantation and Chimeric Antigen Receptor-T Cell TherapyArpita P Gandhi, Catherine J Lee
Leukemia & Lymphoma|September 30, 2016
Pharmacologic maintenance strategies following allogeneic hematopoietic cell transplantation for acute myeloid leukemiaCatherine J Lee, Parveen Shiraz, Lori Muffly
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 14, 2018
Varicella Zoster Virus Reactivation in Adult Survivors of Hematopoietic Cell Transplantation: How Do We Best Protect Our Patients?Catherine J Lee, Bipin N Savani, Per Ljungman
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 18, 2018
Multifaceted Burden of Chronic Graft-versus-Host DiseaseVedran Radojcic, Catherine J Lee, Daniel R Couriel
British Journal of Haematology|August 17, 2021
Beyond ruxolitinib in steroid-refractory acute graft-versus-host diseaseCatherine J Lee, Iskra Pusic, Bipin N Savani
Hematology/Oncology Clinics of North America|July 28, 2010
Oral IIa inhibitorsCatherine J Lee, Gauri Badhwar, Jack E Ansell
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Current Hematologic Malignancy Reports|January 11, 2022
Use of Telemedicine in Care of Hematologic Malignancy Patients: Challenges and OpportunitiesJennifer Lloyd, Catherine J Lee
British Journal of Clinical Pharmacology|January 19, 2011
Direct thrombin inhibitorsCatherine J Lee, Jack E Ansell
JACC. Cardiooncology|January 11, 2024
Ablating Late Cardiovascular Events in Modern Hematopoietic Cell Transplantation: Not There YetRichard K Cheng, Catherine J Lee
Current Hematologic Malignancy Reports|May 24, 2017
Coordination of Care in Survivorship After Treatment of Hematological Malignancies-The Journey is Not Over YetCatherine J Lee, Lori S Muffly
Cancers|August 26, 2023
Telemedicine in Hematopoietic Cell Transplantation and Chimeric Antigen Receptor-T Cell TherapyArpita P Gandhi, Catherine J Lee
Leukemia & Lymphoma|September 30, 2016
Pharmacologic maintenance strategies following allogeneic hematopoietic cell transplantation for acute myeloid leukemiaCatherine J Lee, Parveen Shiraz, Lori Muffly
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 14, 2018
Varicella Zoster Virus Reactivation in Adult Survivors of Hematopoietic Cell Transplantation: How Do We Best Protect Our Patients?Catherine J Lee, Bipin N Savani, Per Ljungman
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 18, 2018
Multifaceted Burden of Chronic Graft-versus-Host DiseaseVedran Radojcic, Catherine J Lee, Daniel R Couriel
British Journal of Haematology|August 17, 2021
Beyond ruxolitinib in steroid-refractory acute graft-versus-host diseaseCatherine J Lee, Iskra Pusic, Bipin N Savani
Hematology/Oncology Clinics of North America|July 28, 2010
Oral IIa inhibitorsCatherine J Lee, Gauri Badhwar, Jack E Ansell
Pageof 8